# Satellogic Inc.: financial statements, quarterly

SATL · Nasdaq · CIK 1874315 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/satl.md) · [Financials](/companies/satl/financials.md) · [Filings](/companies/satl/filings.md) · [Insiders](/companies/satl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/satl/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.3](/filings/0001628280-25-025087.md) | [3.5](/filings/0001874315-25-000014.md) | [2.8](/filings/0001874315-25-000019.md) | [3.2 d](/filings/0001874315-26-000013.md) | [3.4](/filings/0001874315-26-000016.md) | [4.4](/filings/0001874315-26-000032.md) | [3.6](/filings/0001874315-25-000019.md) | [6.2 d](/filings/0001874315-26-000013.md) | [6.1](/filings/0001874315-26-000016.md) | [15.9](/filings/0001874315-26-000032.md) |
| Research and development | $m | [2.2](/filings/0001628280-25-025087.md) | [2.3](/filings/0001874315-25-000014.md) | [1.3](/filings/0001874315-25-000019.md) | [1.7 d](/filings/0001874315-26-000013.md) | [1.4](/filings/0001874315-26-000016.md) | [1.2](/filings/0001874315-26-000032.md) | [1.2](/filings/0001874315-25-000019.md) | [1.2 d](/filings/0001874315-26-000013.md) | [1.4](/filings/0001874315-26-000016.md) | [1.5](/filings/0001874315-26-000032.md) |
| Selling, general and administrative | $m | [9.4](/filings/0001628280-25-025087.md) | [9.5](/filings/0001874315-25-000014.md) | [6.7](/filings/0001874315-25-000019.md) | [7.4 d](/filings/0001874315-26-000013.md) | [6.5](/filings/0001874315-26-000016.md) | [5.4](/filings/0001874315-26-000032.md) | [6.4](/filings/0001874315-25-000019.md) | [7.5 d](/filings/0001874315-26-000013.md) | [6.5](/filings/0001874315-26-000016.md) | [8.6](/filings/0001874315-26-000032.md) |
| Operating income | $m | [(14.6)](/filings/0001628280-25-025087.md) | [(14.7)](/filings/0001874315-25-000014.md) | [(11.5)](/filings/0001874315-25-000019.md) | [(11.4) d](/filings/0001874315-26-000013.md) | [(9.5)](/filings/0001874315-26-000016.md) | [(6.3)](/filings/0001874315-26-000032.md) | [(8.1)](/filings/0001874315-25-000019.md) | [(7.1) d](/filings/0001874315-26-000013.md) | [(6.4)](/filings/0001874315-26-000016.md) | [0.3](/filings/0001874315-26-000032.md) |
| Income tax | $m | [1.4](/filings/0001628280-25-025087.md) | [0.4](/filings/0001874315-25-000014.md) | [0.3](/filings/0001874315-25-000019.md) | [0.8 d](/filings/0001874315-26-000013.md) | [0.7](/filings/0001874315-26-000016.md) | [(0.0)](/filings/0001874315-26-000032.md) | [0.1](/filings/0001874315-25-000019.md) | [(0.1) d](/filings/0001874315-26-000013.md) | [0.0](/filings/0001874315-26-000016.md) | [1.9](/filings/0001874315-26-000032.md) |
| Net income | $m | [(15.2)](/filings/0001874315-25-000019.md) | [(18.1)](/filings/0001874315-25-000019.md) | [(12.1)](/filings/0001874315-25-000019.md) | [(70.9) d](/filings/0001874315-26-000013.md) | [(32.6)](/filings/0001874315-26-000032.md) | [(6.7)](/filings/0001874315-26-000032.md) | [4.0](/filings/0001874315-25-000019.md) | [30.5 d](/filings/0001874315-26-000013.md) | [(118)](/filings/0001874315-26-000032.md) | [(20.0)](/filings/0001874315-26-000032.md) |
| Diluted EPS | $ per share | [(0.17)](/filings/0001628280-25-025087.md) | [(0.20)](/filings/0001874315-25-000014.md) | [(0.13)](/filings/0001874315-25-000019.md) | not reported | [(0.34)](/filings/0001874315-26-000016.md) | [(0.06)](/filings/0001874315-26-000032.md) | [(0.02)](/filings/0001874315-25-000019.md) | not reported | [(0.84)](/filings/0001874315-26-000016.md) | [(0.13)](/filings/0001874315-26-000032.md) |
| Basic EPS | $ per share | [(0.17)](/filings/0001628280-25-025087.md) | [(0.20)](/filings/0001874315-25-000014.md) | [(0.13)](/filings/0001874315-25-000019.md) | not reported | [(0.34)](/filings/0001874315-26-000016.md) | [(0.06)](/filings/0001874315-26-000032.md) | [0.04](/filings/0001874315-25-000019.md) | not reported | [(0.84)](/filings/0001874315-26-000016.md) | [(0.13)](/filings/0001874315-26-000032.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [76.5](/filings/0001628280-24-016229.md) | [23.5](/filings/0001628280-25-014951.md) | not reported | not reported | not reported | [22.5](/filings/0001874315-26-000013.md) | [17.7](/filings/0001628280-25-025087.md) | [32.6](/filings/0001874315-25-000014.md) | [28.3](/filings/0001874315-25-000019.md) | [94.4](/filings/0001874315-26-000032.md) | [122](/filings/0001874315-26-000016.md) | [113](/filings/0001874315-26-000032.md) |
| Current assets | $m | [81.2](/filings/0001628280-24-016229.md) | [26.6](/filings/0001628280-25-014951.md) | not reported | not reported | not reported | [27.9](/filings/0001874315-26-000013.md) | [24.1](/filings/0001628280-25-025087.md) | [37.3](/filings/0001874315-25-000014.md) | [35.5](/filings/0001874315-25-000019.md) | [115](/filings/0001874315-26-000032.md) | [145](/filings/0001874315-26-000016.md) | [140](/filings/0001874315-26-000032.md) |
| Total assets | $m | [144](/filings/0001628280-24-016229.md) | [76.4](/filings/0001628280-25-014951.md) | not reported | not reported | not reported | [61.7](/filings/0001874315-26-000013.md) | [61.4](/filings/0001628280-25-025087.md) | [73.8](/filings/0001874315-25-000014.md) | [70.9](/filings/0001874315-25-000019.md) | [151](/filings/0001874315-26-000032.md) | [188](/filings/0001874315-26-000016.md) | [196](/filings/0001874315-26-000032.md) |
| Current liabilities | $m | [30.1](/filings/0001628280-24-016229.md) | [21.4](/filings/0001628280-25-014951.md) | not reported | not reported | not reported | [34.6](/filings/0001874315-26-000013.md) | [41.6](/filings/0001628280-25-025087.md) | [38.1](/filings/0001874315-25-000014.md) | [32.9](/filings/0001874315-25-000019.md) | [22.5](/filings/0001874315-26-000032.md) | [59.1](/filings/0001874315-26-000016.md) | [59.8](/filings/0001874315-26-000032.md) |
| Total liabilities | $m | [37.7](/filings/0001628280-24-016229.md) | [24.7](/filings/0001628280-25-014951.md) | not reported | not reported | not reported | [115](/filings/0001874315-26-000013.md) | [144](/filings/0001628280-25-025087.md) | [142](/filings/0001874315-25-000014.md) | [128](/filings/0001874315-25-000019.md) | [90.8](/filings/0001874315-26-000032.md) | [214](/filings/0001874315-26-000016.md) | [162](/filings/0001874315-26-000032.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | [0.0](/filings/0001628280-23-013665.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [106](/filings/0001628280-25-014951.md) | [51.7](/filings/0001874315-26-000013.md) | [37.6](/filings/0001874315-25-000019.md) | [19.1](/filings/0001874315-25-000019.md) | [7.8](/filings/0001874315-25-000019.md) | [(53.0)](/filings/0001874315-26-000032.md) | [(83.1)](/filings/0001874315-26-000032.md) | [(68.1)](/filings/0001874315-26-000032.md) | [(56.9)](/filings/0001874315-25-000019.md) | [60.5](/filings/0001874315-26-000032.md) | [(25.5)](/filings/0001874315-26-000032.md) | [33.9](/filings/0001874315-26-000032.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(10.1)](/filings/0001628280-25-025087.md) | [(13.8) d](/filings/0001874315-25-000014.md) | [(8.4) d](/filings/0001874315-25-000019.md) | [(3.6) d](/filings/0001874315-26-000013.md) | [(4.7)](/filings/0001874315-26-000016.md) | [(4.3) d](/filings/0001874315-26-000032.md) | [(8.4) d](/filings/0001874315-25-000019.md) | [(9.5) d](/filings/0001874315-26-000013.md) | [0.2](/filings/0001874315-26-000016.md) | [(8.6) d](/filings/0001874315-26-000032.md) |
| Capital expenditure | $m | [1.9](/filings/0001628280-25-025087.md) | [1.4 d](/filings/0001874315-25-000014.md) | [1.0 d](/filings/0001874315-25-000019.md) | [0.7 d](/filings/0001874315-26-000013.md) | [1.9](/filings/0001874315-26-000016.md) | [0.8 d](/filings/0001874315-26-000032.md) | [1.3 d](/filings/0001874315-25-000019.md) | [3.3 d](/filings/0001874315-26-000013.md) | [5.6](/filings/0001874315-26-000016.md) | [5.6 d](/filings/0001874315-26-000032.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [90.3](/filings/0001628280-25-025087.md) | [90.7](/filings/0001874315-25-000014.md) | [91.2](/filings/0001874315-25-000019.md) | [96.7](/filings/0001874315-26-000016.md) | [103](/filings/0001874315-26-000032.md) | [131](/filings/0001874315-25-000019.md) | [141](/filings/0001874315-26-000016.md) | [151](/filings/0001874315-26-000032.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 27,297,969 at 2022-04-25, from the cover of the [20-F/A filed 2022-05-16](/filings/0001193125-22-151800.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.